Company Profiles

driven by the PitchBook Platform

Actinobac Biomed

Description

Developer of pharmaceutical technologies based upon agents which target Leukocyte Function Antigen-1. The company develops pharmaceutical agents for the treatment of hematologic malignancies (leukemias & lymphomas), latent infections (HIV/AIDS & tuberculosis) and autoimmune diseases (rheumatoid arthritis, multiple sclerosis, Crohn's disease, type 1 diabetes, Lupus & psoriasis).

2009

Founded

PRIVATE

Status

1-10

Employees

Grant

Latest Deal Type

$905k

Latest Deal Amount

$1.1M

Total Amount Raised

Description

Developer of pharmaceutical technologies based upon agents which target Leukocyte Function Antigen-1. The company develops pharmaceutical agents for the treatment of hematologic malignancies (leukemias & lymphomas), latent infections (HIV/AIDS & tuberculosis) and autoimmune diseases (rheumatoid arthritis, multiple sclerosis, Crohn's disease, type 1 diabetes, Lupus & psoriasis).

Website:

www.actinobac.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Therapeutic Devices

Other Industries

Biotechnology
Pharmaceuticals

Primary Office

15 Pelham Road Kendall Park, NJ 08824United States +1 (732) 371-2694
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Actinobac Biomed's full profile, request a free trial.

Actinobac Biomed Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Actinobac Biomed Investors (2)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Foundation Venture Capital GroupVenture CapitalMinority000 0000000 0000
National Cancer InstituteGovernment000 0000000 0000
Foundation Venture Capital Group Venture Capital
National Cancer Institute Government

Actinobac Biomed Executive Team (1)

NameTitleBoard
Seat
Contact
Info
Benjamin Belinka Ph.DPresident & Chief Executive Officer
Benjamin Belinka Ph.D President & Chief Executive Officer

Actinobac Biomed Board Members (1)

NameRepresentingRoleSinceContact
Info
Scott Kachlany Ph.DSelfFounder, Chief Scientific Officer & Chairman, Scientific Advisory000 0000
Scott Kachlany Ph.D Founder, Chief Scientific Officer & Chairman, Scientific Advisory Self
Request full access to PitchBook